Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00734838 · ClinicalTrials.gov registry record · NA
Optical Spectroscopy During Breast Cancer Surgery and Core Needle Biopsy
A NA study of Breast Cancer, sponsored by Duke University.
- Completed
- Registry status
- NA
- Development phase
- 213
- Enrollment target
- 1
- Study location
NCT00734838: Completed NA study of Breast Cancer, sponsored by Duke University.
NCT00734838 is a NA study of Breast Cancer that has completed, run by Duke University. The registered enrollment target is 213 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00734838, a NA study of Breast Cancer, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- NA
- Development phase
- 213 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective of the proposed research is to develop new diagnostic modalities based on optical spectroscopy (auto fluorescence, absorption, and scattering) for the diagnosis of breast cancer and test its performance as an adjunct to core needle biopsy. For the surgery part of the study, all patients scheduled to have a mastectomy or lumpectomy for the treatment of breast cancer will be asked if they would be willing to participate in this study. For the core needle biopsy part of the study, patients with a higher pre-probability of cancer (based on mammography) will be recruited to increase the number of patients with malignant lesions and enrolled in this investigation.
Primary Outcome
The primary outcome of this study is the identification of the optical signatures of normal and cancerous tissue of the breast
Conditions Studied
Interventions
- DEVICE High Resolution Microendoscope
Study Locations (1)
North Carolina
- Duke University Medical Center - Durham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 213 participants |
| Start Date | 2006-01 |
| Est. Completion | 2022-10-03 |
| Phase | NA |
What the finished NCT00734838 record still lists
NCT00734838 is an interventional study that assigns participants to a tested intervention. The registered 213 participants enrollment target is mid-sized for trials with a published cap, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (92% lower).
The record links to 1 condition, with Breast Cancer appearing as the primary indexed condition, and to 1 intervention - of which High Resolution Microendoscope is the first listed.
NCT00734838 reports a single indexed study location in North Carolina.
Frequently Asked Questions
What is clinical trial NCT00734838 about?
NCT00734838 is a clinical study titled "Optical Spectroscopy During Breast Cancer Surgery and Core Needle Biopsy". The objective of the proposed research is to develop new diagnostic modalities based on optical spectroscopy (auto fluorescence, absorption, and scattering) for the diagnosis of breast cancer and test its performance as an adjunct to core needle biopsy. For the surgery part of the study, all patient...
What is the current status of trial NCT00734838?
This trial is currently completed. It is a NA study. The enrollment target is 213 participants. The study started on 2006-01. Estimated completion is 2022-10-03.
What conditions does trial NCT00734838 study?
This clinical trial studies the following conditions: Breast Cancer.
What interventions are being tested in trial NCT00734838?
The interventions under investigation include: High Resolution Microendoscope (DEVICE).
Who is sponsoring clinical trial NCT00734838?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00734838 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00734838's enrollment target sits among peer trials
213 351st of 1224 higher than 873 of 1,224 other Breast Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Breast Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Harnessing Analysis RNA Expression and Molecular Subtype to Optimize Novel TherapY MBCA
RECRUITING · NA
-
Post-operative Radiotherapy Omission in Selected Patients With Early Breast Cancer Trial International VErsion (PROSPECTIVE)
RECRUITING · NA
-
Resistance and Aerobic Exercise for Prevention in Women With Dense Breasts (REP-D)
RECRUITING · NA
-
Partial Breast Re-irradiation Using Ultra Hypofractionation (PRESERVE)
RECRUITING · NA
-
A Randomized Controlled Trial (RCT) to Determine the Efficacy of a Multidisciplinary CBT Based Pain Management Program for the Treatment of Aromatase Inhibitor Associated Musculoskeletal Symptoms (AIMSS) in Breast Cancer Survivors
RECRUITING · NA
-
Precise Oncology Interventions in Nutrition and Training (OnPoint)
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06476886 · 213 participants · NA
Intensive Crisis Intervention
- NCT06544655 · 213 participants · Phase 1
A Study of BMS-986484 Alone and Combination Therapy in Participants With Advanced Solid Tumors
- NCT07186816 · 213 participants · NA
SUpport From PEeRs to Expand Access Study - Community
- NCT04421248 · 214 participants · Phase 4
Biomarker Validation in Motor System Physiology in Attention Deficit Hyperactivity Disorder
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia